σ1 Receptor modulation of G-protein-coupled receptor signaling: Potentiation of opioid transduction independent from receptor binding

Molecular Pharmacology

Volumn 77, Issue 4, 2010, Pages 695-703

  Kim, Felix J ^a   Kovalyshyn, Ivanka ^a   Burgman, Maxim ^a   Neilan, Claire ^a   Chien, Chih Cheng ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DI 2 TOLYLGUANIDINE; 5' O [3 [S 35]THIO]TRIPHOSPHATE; CYCLAZOCINE; G PROTEIN COUPLED RECEPTOR; GUANOSINE DERIVATIVE; HALOPERIDOL; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N ALLYLNORMETAZOCINE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PENTAZOCINE; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RNA INTERFERENCE;

ANIMALS; BINDING SITES; CELLS, CULTURED; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ETHYLENEDIAMINES; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; MICE; PENTAZOCINE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; RECEPTORS, SIGMA; SIGNAL TRANSDUCTION;

EID: 77950226055     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.057083     Document Type: Article

References (46)

1. Aydar E, Palmer CP, and Djamgoz MB (2004) Sigma receptors and cancer: possible involvement of ion channels. Cancer Res 64:5029-5035.
2. Aydar E, Palmer CP, Klyachko VA, and Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34:399-410.
3. Bermack JE and Debonnel G (2005) The role of sigma receptors in depression. J Pharmacol Sci 97:317-336.
4. Bolan EA, Pan YX, and Pasternak GW (2004) Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm. Synapse 51:11-18.
5. Bowen WD (2000) Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv 74:211-218.
6. 3H](+)-pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors. Mol Neuropharmacol 3:117-126.
7. 125I]3′(-)-iodopentazocine, a selective 1 receptor ligand. Eur J Pharmacol 321:361-368.
8. Chien CC and Pasternak GW (1993) Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid 1 system. Eur J Pharmacol 250:R7-R8.
9. Chien CC and Pasternak GW (1994) Selective antagonism of opioid analgesia by a sigma system. J Pharmacol Exp Ther 271:1583-1590.
10. Chien CC and Pasternak GW (1995) Sigma antagonists potentiate opioid analgesia in rats. Neurosci Lett 190:137-139.
11. Christopoulos A and Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54:323-374.
12. Crawford KW, Coop A, and Bowen WD (2002) Sigma(2) receptors regulate changes in sphingolipid levels in breast tumor cells. Eur J Pharmacol 443:207-209.
13. Gebreselassie D and Bowen WD (2004) Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. Eur J Pharmacol 493:19-28.
14. Gundlach AL, Largent BL, and Snyder SH (1986) Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J Neurosci 6:1757-1770.
15. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, and Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 93:8072-8077.
16. Hayashi T and Su TP (2003) Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther 306:718-725.
17. 2+ signaling and cell survival. Cell 131:596-610.
18. Hollinger S and Hepler JR (2002) Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev 54:527-559.
19. Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700.
20. Kekuda R, Prasad PD, Fei YJ, Leibach FH, and Ganapathy V (1996) Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 229:553-558.
21. King MA, Bradshaw S, Chang AH, Pintar JE, and Pasternak GW (2001) Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system. J Neurosci 21:7788-7792.
22. King M, Pan YX, Mei J, Chang A, Xu J, and Pasternak GW(1997) Enhanced kappa-opioid analgesia by antisense targeting the Σ1 receptor. Eur J Pharmacol 331:R5-R6.
23. Lupardus PJ, Wilke RA, Aydar E, Palmer CP, Chen Y, Ruoho AE, and Jackson MB (2000) Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol 526:527-539.
24. Martin WR, Eades CG, Thompson JA, Huppler RE, and Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532.
25. Martina M, Turcotte ME, Halman S, and Bergeron R (2007) The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 578:143-157.
26. Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, and De Costa BR (1995) Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism. Eur J Pharmacol 280:301-310.
27. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, and Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339.
28. 1 receptor. Biochem Pharmacol 62:349-355.
29. 1 receptor modulation of opioid analgesia in the mouse. J Pharmacol Exp Ther 300:1070-1074.
30. Mei J and Pasternak GW (2007) Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study. J Pharmacol Exp Ther 322:1278-1285.
31. 3H]-noradrenaline release in rat hippocampal slices. Br J Pharmacol 119:65-72.
32. Pan YX, Bolan E, and Pasternak GW (2002) Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype. Biochem Biophys Res Commun 297:659-663.
33. Pan YX, Mei J, Xu J, Wan BL, Zuckerman A, and Pasternak GW (1998) Cloning and characterization of a mouse Σ1 receptor. J Neurochem 70:2279-2285.
34. Pitcher JA, Freedman NJ, and Lefkowitz RJ (1998) G protein-coupled receptor kinases. Annu Rev Biochem 67:653-692.
35. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, and Taylor DP (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 13:85-86.
36. Rossi GC, Leventhal L, Bolan E, and Pasternak GW (1997) Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther 282:858-865.
37. Rossi GC, Leventhal L, and Pasternak GW (1996) Naloxone-sensitive orphanin FQ-induced analgesia in mice. Eur J Pharmacol 311:R7-R8.
38. 1 binding in a human neuroblastoma cell line. Neurochem Res 21:1309-1314.
39. Seth P, Fei YJ, Li HW, Huang W, Leibach FH, and Ganapathy V (1998) Cloning and functional characterization of a σ receptor from rat brain. J Neurochem 70:922-931.
40. Seth P, Leibach FH, and Ganapathy V (1997) Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem Biophys Res Commun 241:535-540.
41. Sim LJ, Selley DE, Xiao R, and Childers SR (1996) Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum. Eur J Pharmacol 307:97-105.
42. Spruce BA, Campbell LA, McTavish N, Cooper MA, Appleyard MV, O'Neill M, Howie J, Samson J, Watt S, Murray K, et al. (2004) Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res 64:4875-4886.
43. Standifer KM, Cheng J, Brooks AI, Honrado CP, Su W, Visconti LM, Biedler JL, and Pasternak GW (1994) Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J Pharmacol Exp Ther 270:1246-1255.
44. Ueda H, Yoshida A, Tokuyama S, Mizuno K, Maruo J, Matsuno K, and Mita S (2001) Neurosteroids stimulate G protein-coupled sigma receptors in mouse brain synaptic membrane. Neurosci Res 41:33-40.
45. Vilner BJ, John CS, and Bowen WD (1995) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 55:408-413.
46. 3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study. Brain Res 581:33-38.